復(fù)方丹參滴丸與芪參益氣滴丸在冠心病臨床中的治療分析

打開(kāi)文本圖片集

【摘要】目的：研究復(fù)方丹參滴丸與芪參益氣滴丸在冠心病臨床中的治療效果。方法：選擇2021年5月—2022年5月我院收治的78例冠心病患者，隨機(jī)分為研究組與對(duì)照組，每組39例。對(duì)照組采用芪參益氣滴丸治療，研究組應(yīng)用復(fù)方丹參滴丸治療，對(duì)比兩組臨床療效、治療前后心功能能指標(biāo)、生活質(zhì)量評(píng)分。結(jié)果：研究組治療總有效率高于對(duì)照組；治療后研究組的 FS、 LVEF 更高，LVESV、LVEDV、LVDs、LVDd更低；研究組生活質(zhì)量評(píng)分高于對(duì)照組，數(shù)據(jù)對(duì)比有意義（P

【關(guān)鍵詞】復(fù)方丹參滴丸；芪參益氣滴丸；冠心?。恍墓δ苤笜?biāo)；生活質(zhì)量

Clinical analysis of compound Danshen dripping pills and Qishenyiqi dripping pills in the treatment of coronary heart disease

GAO Jianping

Qingshui People’s Hospital of Gansu Province， Tianshui， Gansu 741400， China

【Abstract】Objective： To study the clinical therapeutic effect of compound Danshen dripping pills and Qishenyiqi dripping pills on coronary heart disease. Methods： 78 patients with coronary heart disease admitted to our hospital from May 2021 to May 2022 were randomly divided into study group and control group， with 39 cases in each group. The control group was treated with Qishenyiqi dripping pills， and the study group was treated with compound Danshen dripping pills. The clinical efficacy， cardiac function indexes and quality of life scores before and after treatment were compared between the two groups. Results： The total effective rate of the study group was higher than that of the control group. FS and LVEF were higher in the study group after treatment， while LVESV， LVEDV， LVDs and LVDd were lower. The quality of life score of the study group was higher than that of the control group（P

【Key Words】Compound Salvia miltiorrhiza dripping pills； Qishenyiqi dropping pill； Coronary heart disease； Cardiac function index； Quality of life

冠狀動(dòng)脈粥樣硬化性心臟病又被稱(chēng)之為冠心病，主要是因?yàn)檠軆?nèi)脂質(zhì)異常所致血管狹窄或阻塞，繼而出現(xiàn)缺氧、缺血等情況，患者的臨床癥狀相對(duì)比較明顯，以心悸、氣短、胸痛、心絞痛等為主要表現(xiàn)[1]。（剩余3552字）